Los Angeles Capital Management LLC Bio Rad Laboratories, Inc. Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$350.25 - $422.63 $3.72 Million - $4.49 Million	-10,614 Reduced 74.32%	3,667 $1.31 Million
Q2 2023 Aug 03, 2023	SELL	$359.49 - $486.4 $61.3 Million - $82.9 Million	-170,515 Reduced 92.27%	14,281 $5.41 Million
Q1 2023 May 04, 2023	BUY	$418.69 - $503.0 $77.4 Million - $93 Million	184,796 New	184,796 $88.5 Million
Q2 2022 Aug 05, 2022	SELL	$463.67 - $597.16 $874,017 - $1.13 Million	-1,885 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$524.57 - $735.42 $3.92 Million - $5.49 Million	-7,466 Reduced 79.84%	1,885 $1.06 Million
Q4 2021 Feb 03, 2022	BUY	$708.84 - $794.68 $5.79 Million - $6.49 Million	8,171 Added 692.46%	9,351 $7.07 Million
Q3 2021 Nov 08, 2021	BUY	$657.71 - $825.77 $776,097 - $974,408	1,180 New	1,180 $880,000
Q1 2021 May 05, 2021	SELL	$547.01 - $662.35 $470,428 - $569,621	-860 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$510.68 - $643.45 $20,427 - $25,738	-40 Reduced 4.44%	860 $501,000
Q3 2020 Nov 02, 2020	BUY	$454.43 - $535.6 $18,177 - $21,424	40 Added 4.65%	900 $464,000
Q2 2020 Aug 05, 2020	SELL	$334.87 - $493.06 $294,685 - $433,892	-880 Reduced 50.57%	860 $388,000
Q1 2020 May 04, 2020	SELL	$320.01 - $409.07 $22,400 - $28,634	-70 Reduced 3.87%	1,740 $610,000
Q4 2019 Feb 07, 2020	SELL	$319.73 - $374.2 $578,391 - $676,927	-1,809 Reduced 49.99%	1,810 $670,000
Q3 2019 Nov 07, 2019	SELL	$304.55 - $345.24 $2.23 Million - $2.53 Million	-7,324 Reduced 66.93%	3,619 $1.2 Million
Q2 2019 Jul 29, 2019	BUY	$286.93 - $312.59 $341,446 - $371,982	1,190 Added 12.2%	10,943 $3.42 Million
Q1 2019 Apr 25, 2019	BUY	$224.3 - $317.41 $1.29 Million - $1.82 Million	5,730 Added 142.43%	9,753 $2.98 Million
Q4 2018 Feb 11, 2019	SELL	$220.1 - $309.0 $767,048 - $1.08 Million	-3,485 Reduced 46.42%	4,023 $934,000
Q3 2018 Nov 05, 2018	SELL	$289.28 - $326.15 $7.53 Million - $8.49 Million	-26,035 Reduced 77.62%	7,508 $2.35 Million
Q2 2018 Jul 31, 2018	SELL	$244.1 - $303.88 $622,455 - $774,894	-2,550 Reduced 7.07%	33,543 $9.68 Million
Q1 2018 Apr 27, 2018	BUY	$233.97 - $274.11 $955,767 - $1.12 Million	4,085 Added 12.76%	36,093 $9.03 Million
Q4 2017 Feb 05, 2018	SELL	$216.94 - $271.3 $88,945 - $111,233	-410 Reduced 1.26%	32,008 $7.64 Million
Q3 2017 Nov 06, 2017	SELL	$212.27 - $242.28 $228,402 - $260,693	-1,076 Reduced 3.21%	32,418 $7.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	33,494	33,494 $7.58 Million

Others Institutions Holding BIO

# of Institutions

458

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account